Who owns TuHURA Biosciences, Inc./NV?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of HURA from SEC Form 13F filings across 88 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 88 institutions disclosed 8.9M shares of TuHURA Biosciences, Inc./NV worth $20.7M — about 13.9% of shares outstanding; the largest disclosed holder is VANGUARD CAPITAL MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
88
13F holders
$20.7M
value, 2026 filers
13.9%
of shares outstanding (8.9M sh)
25
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of HURA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 2.3M | $5.3M | 0.0% | 3.5% | +9.3% |
| 2 | NORTHERN TRUST CORP | 1.6M | $3.8M | 0.0% | 2.5% | +443.6% |
| 3 | BlackRock, Inc. | 690,088 | $1.6M | 0.0% | 1.1% | -71.8% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 484,219 | $1.1M | 0.0% | 0.8% | -50.9% |
| 5 | MILLENNIUM MANAGEMENT LLCNEW | 454,535 | $1.1M | 0.0% | 0.7% | new |
| 6 | AQR CAPITAL MANAGEMENT LLC | 424,600 | $993,563 | 0.0% | 0.7% | -30.1% |
| 7 | VANGUARD FIDUCIARY TRUST CO | 251,186 | $587,775 | 0.0% | 0.4% | -12.5% |
| 8 | CITADEL ADVISORS LLCNEW | 232,319 | $543,627 | 0.0% | 0.4% | new |
| 9 | STATE STREET CORP | 188,404 | $440,865 | 0.0% | 0.3% | -63.3% |
| 10 | JANE STREET GROUP, LLCNEW | 163,891 | $383,505 | 0.0% | 0.3% | new |
| 11 | Apollon Wealth Management, LLC | 156,519 | $366,254 | 0.0% | 0.2% | -0.9% |
| 12 | Qube Research & Technologies LtdNEW | 145,595 | $340,692 | 0.0% | 0.2% | new |
| 13 | MORGAN STANLEY | 143,257 | $335,222 | 0.0% | 0.2% | +501.1% |
| 14 | GOLDMAN SACHS GROUP INC | 131,768 | $308,337 | 0.0% | 0.2% | +87.6% |
| 15 | Bank of New York Mellon Corp | 121,662 | $284,689 | 0.0% | 0.2% | -42.5% |
| 16 | XTX Topco Ltd | 100,424 | $234,992 | 0.0% | 0.2% | +772.3% |
| 17 | WealthShield Partners, LLC | 91,530 | $214,180 | 0.0% | 0.1% | 0.0% |
| 18 | CAPTRUST FINANCIAL ADVISORSNEW | 88,373 | $206,793 | 0.0% | 0.1% | new |
| 19 | Cetera Investment Advisers | 61,620 | $144,191 | 0.0% | 0.1% | -56.1% |
| 20 | UBS Group AG | 56,321 | $131,791 | 0.0% | 0.1% | -9.3% |
| 21 | Catalyst Funds Management Pty LtdNEW | 47,201 | $110,450 | 0.0% | 0.1% | new |
| 22 | BRIGHTON JONES LLCNEW | 47,010 | $110,004 | 0.0% | 0.1% | new |
| 23 | TUDOR INVESTMENT CORP ET ALNEW | 45,115 | $105,569 | 0.0% | 0.1% | new |
| 24 | BANK OF AMERICA CORP /DE/ | 42,506 | $99,464 | 0.0% | 0.1% | -45.6% |
| 25 | Invst, LLC | 42,506 | $99,464 | 0.0% | 0.1% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.